283 related articles for article (PubMed ID: 17201236)
21. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
Wilson AM; Orr LC; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
[TBL] [Abstract][Full Text] [Related]
22. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
[TBL] [Abstract][Full Text] [Related]
23. The effect of montelukast sodium on serum arginase levels in patients with seasonal allergic rhinitis.
Yasar H; Kiran B; Cagatay T; Ozkul H; Icten S
Am J Rhinol Allergy; 2011; 25(4):e153-5. PubMed ID: 21439134
[TBL] [Abstract][Full Text] [Related]
24. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
26. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
28. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
29. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
30. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
31. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
van Adelsberg J; Philip G; Pedinoff AJ; Meltzer EO; Ratner PH; Menten J; Reiss TF;
Allergy; 2003 Dec; 58(12):1268-76. PubMed ID: 14616102
[TBL] [Abstract][Full Text] [Related]
32. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
[TBL] [Abstract][Full Text] [Related]
34. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
[TBL] [Abstract][Full Text] [Related]
36. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
Stelmach I; Majak P; Jerzynska J; Kuna P
Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
[TBL] [Abstract][Full Text] [Related]
37. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
[TBL] [Abstract][Full Text] [Related]
38. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
39. Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study.
Braido F; Riccio AM; Rogkakou A; Massacane P; Guerra L; Fumagalli F; Stagi E; Balestracci S; Porcu A; Canonica GW
Eur Ann Allergy Clin Immunol; 2012 Apr; 44(2):48-53. PubMed ID: 22768723
[TBL] [Abstract][Full Text] [Related]
40. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
Goh BS; Ismail MI; Husain S
J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
